American Journal of Kidney Diseases
Volume 54, Issue 5 , Pages 840-849 , November 2009

Nephrotic Syndrome in Diabetic Kidney Disease: An Evaluation and Update of the Definition

  • Nicholas Stoycheff, MD, MS

      Affiliations

    • Division of Nephrology, Tufts Medical Center, Boston, MA
    • Corresponding Author InformationAddress correspondence to Nicholas Stoycheff, MD, MS, Division of Nephrology, Tufts Medical Center, 800 Washington St, Box 391, Boston, MA 02111
    • ,
  • Lesley A. Stevens, MD, MS

      Affiliations

    • Division of Nephrology, Tufts Medical Center, Boston, MA
    • ,
  • Christopher H. Schmid, PhD

      Affiliations

    • Division of Clinical Care Research, Biostatistics Research Center, Tufts Medical Center, Boston, MA
    • ,
  • Hocine Tighiouart, MS

      Affiliations

    • Division of Clinical Care Research, Biostatistics Research Center, Tufts Medical Center, Boston, MA
    • ,
  • Julia Lewis, MD

      Affiliations

    • Division of Nephrology, Vanderbilt Medical Center, Nashville, TN
    • ,
  • Robert C. Atkins, MD

      Affiliations

    • Department of Nephrology, Monash Medical Centre, Victoria, Australia
    • ,
  • Andrew S. Levey, MD

      Affiliations

    • Division of Nephrology, Tufts Medical Center, Boston, MA

Received 19 December 2008 ,Accepted 15 April 2009.

References 

  1. Brenner BM, Levine SA, Rector FC MD Consult LLC. Brenner & Rector's The Kidney. (ed 7). Philadelphia, PA: Saunders; 2004;
  2. Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med. 1998;338:1202–1211
  3. Rivera F, Lopez-Gomez JM, Perez-Garcia R. Clinicopathologic correlations of renal pathology in Spain. Kidney Int. 2004;66:898–904
  4. Hunt LP, Short CD, Mallick NP. Prognostic indicators in patients presenting with the nephrotic syndrome. Kidney Int. 1988;34:382–388
  5. Ordonez JD, Hiatt RA, Killebrew EJ, Fireman BH. The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int. 1993;44:638–642
  6. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr. 1981;98:561–564
  7. Fox TF, Douglas-Wilson I. The nephrotic syndrome. Lancet. 1958;2:1000–1002
  8. Jay V. Richard Bright—Physician extraordinaire. Arch Pathol Lab Med. 2000;124:1262–1263
  9. Peitzman SJ. From dropsy to Bright's disease to end-stage renal disease. Milbank Q. 1989;67(suppl 1):S16–S32
  10. Strauss MB, Welt LG. Diseases of the Kidney. (ed 2). Boston, MA: Little Brown; 1963;
  11. Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med. 1983;309:1543–1546
  12. Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: A position statement from the National Kidney Foundation. Am J Kidney Dis. 2007;50:169–180
  13. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S93–S102
  14. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(suppl 2):S12–S154
  15. Miller WG, Bruns DE, Hortin GL, et al. Current issues in measurement and reporting of urinary albumin. Clin Chem. 2009;55:24–38
  16. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851–860
  17. Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61:92–105
  18. Atkins RC, Briganti EM, Lewis JB, et al. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis. 2005;45:281–287
  19. Eknoyan G. A history of edema and its management. Kidney Int Suppl. 1997;59:S118–S126
  20. Heidland A, Gerabek W, Sebekova K. Franz Volhard and Theodor Fahr: Achievements and controversies in their research in renal disease and hypertension. J Hum Hypertens. 2001;15:5–16
  21. Epstein AA. A contribution to the study of the chemistry of blood serum. J Exp Med. 1912;16:719–731
  22. Epstein AA. Further studies on the chemistry of blood serum. J Exp Med. 1913;17:444–452
  23. Epstein AA. Studies on the chemistry of serous effusions. J Exp Med. 1914;20:334–345
  24. Epstein AA. Concerning the causation of edema in chronic parenchymatous nephritis; Method for its alleviation. Am J Med Sci. 1917;154:638–647
  25. Becker GJ. Which albumin should we measure?. Kidney Int Suppl. 2004;92:S16–S17
  26. Nelson RG, Bennett PH, Beck GJ, et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus (Diabetic Renal Disease Study Group). N Engl J Med. 1996;335:1636–1642
  27. Myers BD, Nelson RG, Tan M, et al. Progression of overt nephropathy in non-insulin-dependent diabetes. Kidney Int. 1995;47:1781–1789
  28. Lemley KV, Blouch K, Abdullah I, et al. Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol. 2000;11:2095–2105
  29. Appel GB, Blum CB, Chien S, Kunis CL, Appel AS. The hyperlipidemia of the nephrotic syndrome (Relation to plasma albumin concentration, oncotic pressure, and viscosity). N Engl J Med. 1985;312:1544–1548
  30. Fauchald P, Norseth J, Jervell J. Transcapillary colloid osmotic gradient, plasma volume and interstitial fluid volume in long-term type 1 (insulin-dependent) diabetes. Diabetologia. 1985;28:269–273
  31. Hommel E, Mathiesen ER, Aukland K, Parving HH. Pathophysiological aspects of edema formation in diabetic nephropathy. Kidney Int. 1990;38:1187–1192
  32. O'Brien T, Nguyen TT, Zimmerman BR. Hyperlipidemia and diabetes mellitus. Mayo Clin Proc. 1998;73:969–976
  33. Kissebah AH, Alfarsi S, Evans DJ, Adams PW. Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus. J Clin Invest. 1983;71:655–667
  34. Sampietro T, Bertuglia S, Colantuoni A, Bionda A, Lenzi S, Donato L. Increased permeability of hamster microcirculation to glycosylated albumin. Lancet. 1987;2:994–996
  35. Eknoyan G, Hostetter T, Bakris GL, et al. Proteinuria and other markers of chronic kidney disease: A position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis. 2003;42:617–622
  36. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147
  37. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169
  38. Chonchol M, Lippi G, Montagnana M, Muggeo M, Targher G: Association of inflammation with anaemia in patients with chronic kidney disease not requiring chronic dialysis. Nephrol Dial Transplant 23:2879-2883
  39. Bakker AJ. Detection of microalbuminuria (Receiver operating characteristic curve analysis favors albumin-creatinine ratio over albumin concentration). Diabetes Care. 1999;22:307–313
  40. Chitalia VC, Kothari J, Wells EJ, et al. Cost-benefit analysis and prediction of 24-hour proteinuria from the spot urine protein-creatinine ratio. Clin Nephrol. 2001;55:436–447

 Originally published online as doi: 10.1053/j.ajkd.2009.04.016 on June 26, 2009.

 Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an Associate Editor (Robert Nelson, MD, PhD, National Institutes of Health) who served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

PII: S0272-6386(09)00651-9

doi: 10.1053/j.ajkd.2009.04.016

American Journal of Kidney Diseases
Volume 54, Issue 5 , Pages 840-849 , November 2009

Article Tools

* Image Usage & Resolution